Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Clinical trial NCT05314738 · UNKNOWN

Trial details

NCT number: NCT05314738
Sponsor: Glaukos Corporation
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Progressive Keratoconus

Start date: 2022-03-08
Primary completion: 2025-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.